Obstructive Sleep Apnea, CPAP Treatment & Cognitive Ability in HIV

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 5, 2017

Primary Completion Date

September 13, 2021

Study Completion Date

September 13, 2021

Conditions
HivObstructive Sleep ApneaCognitive Change
Interventions
BEHAVIORAL

CPAP intervention

Participants who agree to participate will be evaluated by a sleep specialist who will confirm eligibility for CPAP treatment.Eligible participants will be referred to VitalAire for initiation of treatment following a standard protocol for CPAP use at home. CPAP treatment will continue until the next visit for the main study, between 4-7 months, based on the timing of the evaluations, after which the study will end.

Trial Locations (1)

H4A 3J1

McGill University Health Center, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

VitalAire

INDUSTRY

collaborator

ResMed

INDUSTRY

lead

McGill University

OTHER